Elite Pharmaceuticals Inc Net Income per Employee (ELTP), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Elite Pharmaceuticals Inc   (ELTP)
 

Elite Pharmaceuticals Inc Net Income per Employee

ELTP's Quarterly Results, Trends, Rankings, Statistics
Elite Pharmaceuticals Inc 's Income per employee grew in the first quarter 2026 on a trailing twelve month basis to , the contribution of Elite Pharmaceuticals Inc 's employees, reached a new high of $ 871,815income per employee.
The Healthcare sector has seen employees of 31 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 334, from total ranking in previous quarter at 549.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELTP Net Income per Employee (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Net Income Change - 8.61 % - - -
Net Income per Employee (TTM) $ 871,815 690,349 667,834 214,208 -166,387
ELTP's Total Ranking # 334 # 549 # 3354 # 3044 # 3906
Seq. Net Income Change -67.98 % -0.71 % 35.7 % - -

ELTP Company Profile >> Back to ELTP Efficiency Comparisons >> Compare ELTP Net Income per Employee to its Competitors

ELTP Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 47
Overall Market # 334

Net Income per Employee Statistics
High Average Low
$ 871,815 $ 83,455 $ -751,418
(Jun 30 2026)   (Jun 30 2014)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Actinium Pharmaceuticals Inc  1,514,120.00 $ 37.853  Million 25 
Ironwood Pharmaceuticals inc   1,298,680.00 $ 129.868  Million 100 
Agenus Inc  1,135,037.04 $ 91.938  Million 81 
Tg Therapeutics Inc   1,106,491.23 $ 441.490  Million 399 
Halozyme Therapeutics Inc   977,768.32 $ 413.596  Million 423 
Zevra Therapeutics Inc   949,245.90 $ 57.904  Million 61 
Protagenic Therapeutics Inc new  910,314.00 $ 5.462  Million 6 
Elite Pharmaceuticals Inc   871,814.86 $ 56.668  Million 65 
The Greater Cannabis Company Inc   740,754.00 $ 0.741  Million 1 
Omeros Corporation  713,291.43 $ 124.826  Million 175 
Prestige Consumer Healthcare Inc   712,757.89 $ 406.272  Million 570 
Atlantic Coastal Acquisition Corp Ii  670,333.33 $ 2.011  Million 3 
Illumina Inc   644,531.25 $ 825.000  Million 1,280 
Liquidia Corporation  641,694.44 $ 138.606  Million 216 
Harmony Biosciences Holdings inc   618,668.94 $ 181.270  Million 293 
Theravance Biopharma inc   597,866.67 $ 53.808  Million 90 
Vaxart Inc   593,676.92 $ 38.589  Million 65 
Glucotrack Inc   554,600.00 $ 8.319  Million 15 
Silexion Therapeutics Corp  489,714.29 $ 6.856  Million 14 
Sanuwave Health Inc   488,872.73 $ 26.888  Million 55 


Date modified: 2026-09-08T15:11:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.